Bone Dose Constraints for Adjuvant Radiation in Resected Extremity Sarcoma
For adult patients with resected extremity sarcoma receiving adjuvant external-beam radiation, apply the following bone constraints: mean dose to bone <37 Gy, volume of bone receiving ≥40 Gy (V40) <64%, and maximum dose to bone <59 Gy, measured on a bone volume contoured 2 cm above and below the planning target volume.
Evidence-Based Bone Constraints
The most robust data comes from a 2025 study 1 demonstrating that implementing specific bone avoidance objectives reduced fracture rates from 4.5% to 1.4% in 700 patients with lower extremity sarcomas. These constraints were validated against earlier foundational work 2 that established the relationship between bone dose parameters and fracture risk.
Specific Dosimetric Parameters:
- Mean dose to bone: <37 Gy - Exceeding this threshold significantly increases fracture risk 2
- V40 (volume receiving ≥40 Gy): <64% - This is the most critical constraint; keeping V40 below 64% substantially reduces fracture incidence 1, 2
- Maximum dose anywhere along bone: <59 Gy - Hot spots above this level correlate with fracture sites 2
- Bone volume definition: 2 cm above and below PTV - This standardized contour ensures consistent constraint application 1
Technical Implementation
Use IMRT or advanced planning techniques to achieve these constraints while maintaining adequate target coverage 3. The NCCN guidelines emphasize that total doses should always be determined by normal tissue tolerance 3, making these bone constraints essential planning objectives rather than optional considerations.
Planning Strategy:
- Contour bone as a distinct organ-at-risk extending 2 cm superior and inferior to the PTV
- Apply constraints as optimization objectives during inverse planning
- Accept minor PTV coverage compromise if necessary to meet bone constraints, particularly when tumor does not directly involve bone
- Document achieved bone doses in treatment summary
Clinical Context and Outcomes
With modern IMRT techniques and these constraints, fracture risk drops to approximately 1.4-1.8% 1, 4. A 2021 study 4 specifically evaluating constraint implementation found 5-year fracture incidence of only 1.8% (95% CI 0.3-12.2%) in the constraint group versus 7.4% in the pre-constraint era, though this difference did not reach statistical significance due to the low event rate.
High-Risk Considerations:
- Age ≥60 years is independently associated with increased fracture risk 4
- Femoral fractures are most common above the knee joint 2
- For very high-risk patients, consider prophylactic intramedullary nailing of the femur 1
Common Pitfalls to Avoid
- Failing to contour bone as OAR: Without explicit bone contouring and constraint application, planning systems will not automatically spare bone
- Inadequate bone volume: Contouring only the bone within the PTV misses the critical adjacent bone that receives substantial dose
- Prioritizing PTV coverage over constraints: When tumor abuts but does not invade bone, bone sparing should take precedence
- Ignoring constraint violations: Even small violations of V40 or maximum dose can increase fracture risk
Standard Radiation Doses
For context, the NCCN guidelines 3 recommend:
- Postoperative RT: 50 Gy to the tumor bed
- Boost for positive margins: Additional 16-18 Gy for microscopic disease, 20-26 Gy for gross residual
- Preoperative RT: 50 Gy in standard fractionation
These target doses remain unchanged; bone constraints are applied as normal tissue limitations during optimization to achieve the therapeutic ratio improvement that modern IMRT enables 5.